Atherosclerosis and oxidant stress: the end of the road for antioxidant vitamin treatment?
about
The role of glucosamine-induced ER stress in diabetic atherogenesisNanocarriers for vascular delivery of antioxidantsOne enzyme, two functions: PON2 prevents mitochondrial superoxide formation and apoptosis independent from its lactonase activityPotential implication of the chemical properties and bioactivity of nitrone spin traps for therapeuticsBoth paraoxonase-1 genotype and activity do not predict the risk of future coronary artery disease; the EPIC-Norfolk Prospective Population Study.Oxidized LDL: diversity, patterns of recognition, and pathophysiology.Vitamin effects on the immune system: vitamins A and D take centre stage.Lycopene dietary intervention: a pilot study in patients with heart failureTranscript and protein analysis reveals better survival skills of monocyte-derived dendritic cells compared to monocytes during oxidative stress.Carvedilol and its new analogs suppress arrhythmogenic store overload-induced Ca2+ releaseVascular dysfunction and chronic obstructive pulmonary disease: the role of redox balance.Inhibition of ROS-induced apoptosis in endothelial cells by nitrone spin traps via induction of phase II enzymes and suppression of mitochondria-dependent pro-apoptotic signaling.Antioxidant plasma concentration and supplementation in carotid intima media thickness.Vascular health in children and adolescents: effects of obesity and diabetes.Individualized cardiovascular risk assessment by cardiovascular magnetic resonance.An exploratory study of dietary intake patterns among adults diagnosed with cardiovascular risk factors.Anti-oxidant and Anti-hypercholesterolemic Activities of Wasabia japonicaAngiotensin II impairs endothelial function via tyrosine phosphorylation of the endothelial nitric oxide synthaseOxidative stress in cardiovascular inflammation: its involvement in autoimmune responses.SOD3 R231G polymorphism associated with coronary artery disease and myocardial infarction. The Ludwigshafen Risk and Cardiovascular Health (LURIC) study.Salvage therapy trial for erectile dysfunction using phosphodiesterase type 5 inhibitors and vitamin E: preliminary report.Zinc deficiency induces vascular pro-inflammatory parameters associated with NF-kappaB and PPAR signaling.Targeting therapeutics to endothelium: are we there yet?The new frontiers of the targeted interventions in the pulmonary vasculature: precision and safety (2017 Grover Conference Series).High-density lipoprotein-associated paraoxonase-1 activity for prediction of adverse outcomes in outpatients with chronic heart failure.Atherosclerosis in primary antiphospholipid syndrome.
P2860
Q26830592-600C667D-D69C-4A5B-8893-0B3303CFDF54Q27027067-86E50D17-1276-4D4C-9E86-198DE0A1E878Q28397498-FDF20B2E-B109-48F5-BA87-E36616FF7FDDQ28818673-4686A34C-09B8-434F-9D9C-9365857266E6Q33497323-2FDE92FA-7F5B-412F-86CD-4CC30EF63809Q33879138-8871CB53-23A4-4385-B142-5016010F88D2Q34005584-546CBB05-A41F-4F7B-A411-793B9FA3EBC1Q34207466-62DEBD03-3A03-409E-BBF4-7A3FA1AF8740Q34391537-86BE6136-A7DA-47EE-942D-589D420CFF80Q35707246-7C8EE942-6C4B-43E0-993F-44F538D13F87Q35766136-187C97EC-F542-41DC-A1EC-0D062FC01B46Q36110071-301A10A9-AE86-4CCE-B966-86FF8F488C01Q37176458-F60AFA3A-BCCA-4F4D-87BB-A56FC6AB469CQ37458921-046403CE-1E23-4975-A2FE-7085DCF08EFAQ38206843-2968C214-8D64-4086-8104-968C36742A73Q40876196-8952D3AF-F249-421A-A91D-A946706BF1F0Q41464492-346DC9A5-33EE-4363-9F79-F0A87CBAAC50Q42463456-E96B2C25-CD3F-4195-9244-5D369B66B4C7Q42791983-D3A85C35-A758-45DC-9C61-E1ECCC131F1DQ45969318-E46EF3DF-8E35-48E4-A58F-CEE9E634F7CFQ46145061-4FEAC7E1-B152-4D3D-B54B-E0D522CF04F4Q46322961-2F92C262-80E6-4305-B04A-FE7E4AAA31B7Q47250590-BA12BD06-4BB5-48E4-A08D-915DD55B8B65Q47675852-54E9A6E1-3CAB-4766-8354-0E7ADA5D3846Q47980523-CFBA45E1-64D8-4C47-B664-7A42458DF898Q52852275-BE0D66E1-8368-41C5-9168-3FDA64D73931
P2860
Atherosclerosis and oxidant stress: the end of the road for antioxidant vitamin treatment?
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Atherosclerosis and oxidant st ...... antioxidant vitamin treatment?
@ast
Atherosclerosis and oxidant st ...... antioxidant vitamin treatment?
@en
type
label
Atherosclerosis and oxidant st ...... antioxidant vitamin treatment?
@ast
Atherosclerosis and oxidant st ...... antioxidant vitamin treatment?
@en
prefLabel
Atherosclerosis and oxidant st ...... antioxidant vitamin treatment?
@ast
Atherosclerosis and oxidant st ...... antioxidant vitamin treatment?
@en
P2093
P2860
P1476
Atherosclerosis and oxidant st ...... antioxidant vitamin treatment?
@en
P2093
Juan-Carlos Kaski
Mika J Thomson
Valentina Puntmann
P2860
P304
P356
10.1007/S10557-007-6027-1
P577
2007-06-01T00:00:00Z